Muscle and nerve dysfunction in rats with experimental galactosaemia.
The effects of up to 4 months dietary supplementation with 40% galactose on muscle and nerve function were examined in rats. Galactitol, a polyol pathway metabolite, accumulated to high levels in both tissues. This led to changes similar to those found in experimental diabetes, which were largely prevented by treatment with an inhibitor of the first enzyme in the pathway, aldose reductase. For fast twitch extensor digitorum longus muscle there was weight loss, fibre damage, slowing of twitch time to peak, increased twitch tension, and reduced tetanic tension. There were no relaxation deficits. For slow twitch soleus there were no changes in tension production. However, contraction and relaxation for both twitch and tetanus were prolonged. Fatigue resistance was reduced after 1 week. Damage in soleus led to a reduction in mean fibre area after 2 months, which largely recovered by 4 months. There was a selective loss of fast oxidative glycolytic fibres. Histochemical staining for succinic dehydrogenase was normal in galactosaemic soleus, in contrast to the marked reduction seen in diabetes. Sciatic nerve conduction velocity was reduced after 2 months, particularly in normally fast conducting motor and sensory fibres. Resistance to hypoxic conduction block was increased in galactosaemic nerves to diabetic levels. It was concluded that polyol pathway hyperactivity is likely to contribute to the aetiology of diabetic myopathy and neuropathy, and that experimental galactosaemia provides a good model in which to study pathway effects without the complicated hormonal changes found in diabetes.
Cameron
N E
NE
School of Biomedical Sciences, Marischal College, University of Aberdeen, Scotland.
Cotter
M A
MA
Robertson
S
S
Cox
D
D
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D050260:Carbohydrate Metabolism; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology; D004376:Galactitol / Q000378:metabolism; D005693:Galactosemias / Q000503:physiopathology*; D008297:Male; D009119:Muscle Contraction; D009132:Muscles / Q000503:physiopathology*; D009420:Nervous System / Q000503:physiopathology*; D009431:Neural Conduction; D051381:Rats; D011919:Rats, Inbred Strains; D013385:Succinate Dehydrogenase / Q000378:metabolism
D004376:Galactitol; D000449:Aldehyde Reductase; D013385:Succinate Dehydrogenase; D000251:Adenosine Triphosphatases